Last update:

Medications news

Medications

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer's disease.

Medications

Study finds sex bias in emergency department pain management

A new study reveals a significant sex bias in pain management at emergency departments, showing that female patients are consistently less likely to receive pain medication prescriptions compared to male patients with similar ...

Medications

A new drug could turn back the clock on multiple sclerosis

Multiple sclerosis (MS) degrades the protective insulation around nerve cells, leaving their axons, which carry electrical impulses, exposed like bare wires. This can cause devastating problems with movement, balance and ...

Medications

Psoriasis drug shows promise for treating childhood diabetes

A drug that is currently used for the treatment of psoriasis has been found to be effective in treating the early stages of type-1 diabetes in children and adolescents, finds a new clinical trial led by Cardiff University.

Medications

New drug candidate blocks resistance to cancer therapies

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation ...

Medications

European medicines watchdog rejects new Alzheimer's drug

Europe's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.

Medications

Anlotinib plus STUPP: A new hope for glioblastoma patients

Glioblastoma multiforme (GBM) is among the most aggressive forms of brain tumors, with few effective treatment options and a bleak prognosis. The current standard of care (SOC), known as the STUPP regimen, includes surgical ...

Medications

US medical advisers vote to recommend Eli Lilly Alzheimer drug

An independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment option available to patients with the devastating brain disorder.

Medications

Oral insulin drops offer relief for diabetes patients

Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain ...